Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

186 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Substitution of Arg-244 by Cys or Ser in SHV-1 and SHV-5 beta-lactamases confers resistance to mechanism-based inhibitors and reduces catalytic efficiency of the enzymes.
Giakkoupi P, Tzelepi E, Legakis NJ, Tzouvelekis LS. Giakkoupi P, et al. FEMS Microbiol Lett. 1998 Mar 1;160(1):49-54. doi: 10.1111/j.1574-6968.1998.tb12889.x. FEMS Microbiol Lett. 1998. PMID: 9495011
In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints.
Papaparaskevas J, Tzouvelekis LS, Tsakris A, Pittaras TE, Legakis NJ; Hellenic Tigecycline Study Group. Papaparaskevas J, et al. Diagn Microbiol Infect Dis. 2010 Feb;66(2):187-94. doi: 10.1016/j.diagmicrobio.2009.09.012. Diagn Microbiol Infect Dis. 2010. PMID: 19836184
In vitro activities of tigecycline against recently isolated Gram-negative anaerobic bacteria in Greece, including metronidazole-resistant strains.
Katsandri A, Avlamis A, Pantazatou A, Petrikkos GL, Legakis NJ, Papaparaskevas J; Hellenic Study Group for Gram-Negative Anaerobic Bacteria. Katsandri A, et al. Diagn Microbiol Infect Dis. 2006 Jul;55(3):231-6. doi: 10.1016/j.diagmicrobio.2006.01.022. Epub 2006 Apr 19. Diagn Microbiol Infect Dis. 2006. PMID: 16626904 Clinical Trial.
Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
Falagas ME, Skalidis T, Vardakas KZ, Legakis NJ; Hellenic Cefiderocol Study Group. Falagas ME, et al. Among authors: legakis nj. J Antimicrob Chemother. 2017 Jun 1;72(6):1704-1708. doi: 10.1093/jac/dkx049. J Antimicrob Chemother. 2017. PMID: 28369471
Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece.
Papaparaskevas J, Pantazatou A, Katsandri A, Houhoula DP, Legakis NJ, Tsakris A, Avlamis A. Papaparaskevas J, et al. J Antimicrob Chemother. 2008 Jul;62(1):137-41. doi: 10.1093/jac/dkn134. Epub 2008 Apr 1. J Antimicrob Chemother. 2008. PMID: 18385145
Frequency and predictors of colonization of the respiratory tract by VIM-2-producing Pseudomonas aeruginosa in patients of a newly established intensive care unit.
Horianopoulou M, Legakis NJ, Kanellopoulou M, Lambropoulos S, Tsakris A, Falagas ME. Horianopoulou M, et al. J Med Microbiol. 2006 Oct;55(Pt 10):1435-1439. doi: 10.1099/jmm.0.46713-0. J Med Microbiol. 2006. PMID: 17005794
VIM-1 metallo-beta-lactamase in Acinetobacter baumannii.
Tsakris A, Ikonomidis A, Pournaras S, Tzouvelekis LS, Sofianou D, Legakis NJ, Maniatis AN. Tsakris A, et al. Emerg Infect Dis. 2006 Jun;12(6):981-3. doi: 10.3201/eid1206.051097. Emerg Infect Dis. 2006. PMID: 16707056 Free PMC article.
Klebsiella pneumoniae infections in Greek hospitals. Dissemination of plasmids encoding an SHV-5 type beta-lactamase.
Legakis NJ, Tzouvelekis LS, Hatzoudis G, Tzelepi E, Gourkou A, Pitt TL, Vatopoulos AC. Legakis NJ, et al. J Hosp Infect. 1995 Nov;31(3):177-87. doi: 10.1016/0195-6701(95)90064-0. J Hosp Infect. 1995. PMID: 8586786
186 results
Jump to page
Feedback